Abstract:AF9 (MLLT3) and its paralog ENL(MLLT1) are members of the YEATS family of proteins with important role in transcriptional and epigenetic regulatory complexes. These proteins are two common MLL fusion partners in MLL‐rearranged leukemias. The oncofusion proteins MLL‐AF9/ENL recruit multiple binding partners, including the histone methyltransferase DOT1L, leading to aberrant transcriptional activation and enhancing the expression of a characteristic set of genes that drive leukemogenesis. The interaction between AF9 and DOT1L is mediated by an intrinsically disordered C‐terminal ANC1 homology domain (AHD) in AF9, which undergoes folding upon binding of DOT1L and other partner proteins. We have recently reported peptidomimetics that disrupt the recruitment of DOT1L by AF9 and ENL, providing a proof‐of‐concept for targeting AHD and assessing its druggability. Intrinsically disordered proteins, such as AF9 AHD, are difficult to study and characterize experimentally on a structural level. In this study, we present a successful protein engineering strategy to facilitate structural investigation of the intrinsically disordered AF9 AHD domain in complex with peptidomimetic inhibitors by using maltose binding protein (MBP) as a crystallization chaperone connected with linkers of varying flexibility and length. The strategic incorporation of disulfide bonds provided diffraction‐quality crystals of the two disulfide‐bridged MBP–AF9 AHD fusion proteins in complex with the peptidomimetics. These successfully determined first series of 2.1–2.6 Å crystal complex structures provide high‐resolution insights into the interactions between AHD and its inhibitors, shedding light on the role of AHD in recruiting various binding partner proteins. We show that the overall complex structures closely resemble the reported NMR structure of AF9 AHD/DOT1L with notable difference in the conformation of the β‐hairpin region, stabilized through conserved hydrogen bonds network. These first series of AF9 AHD/peptidomimetics complex structures are providing insights of the protein–inhibitor interactions and will facilitate further development of novel inhibitors targeting the AF9/ENL AHD domain.

Insights into the Interaction Landscape of the EVH1 Domain of Mena

Native proline-rich motifs exploit sequence context to target actin-remodeling Ena/VASP protein ENAH

Structure of the Homer Evh1 Domain-Peptide Complex Reveals A New Twist in Polyproline Recognition

Elaboration of the Homer1 Recognition Landscape Reveals Incomplete Divergence of Paralogous EVH1 Domains

Characterization of a novel MgtE homolog and its structural dynamics in membrane mimetics

Crystallographic and nuclear magnetic resonance evaluation of the impact of peptide binding to the second PDZ domain of protein tyrosine phosphatase 1E.

Molecular dynamics simulation of the interactions between EHD1 EH domain and multiple peptides

The Structure of the Tiam1 PDZ Domain/ Phospho-Syndecan1 Complex Reveals a Ligand Conformation That Modulates Protein Dynamics.

Prediction of the essential intermolecular contacts for side‐binding of VASP on F‐actin

Discovery of VH domains that allosterically inhibit ENPP1

Enhancement of Protein Mechanical Stability: Correlated Deformations Are Handcuffed by Ligand Binding.

Structural Elucidation of the Binding of the Vav‐SH2 Domain to the EphA2 Cytoplasmic Region

Investigation of the binding specificity of Erbin-PDZ affinity clamp by molecular dynamics simulations

Structural and thermodynamic analysis of PDZ-ligand interactions

The mammalian actin elongation factor ENAH/MENA contributes to autophagosome formation via its actin regulatory function

C‐Terminal Decarboxylation of Proline‐Derived Building Blocks for Protein‐Binding Peptides

Probing Intermolecular Backbone H-bonding in Serine Proteinase-Protein Inhibitor Complexes

Enzymatic, structural, and biophysical characterization of a single‐domain antibody (VHH) selectively and tightly inhibiting neutrophil elastase and exhibiting favorable developability properties

Structural studies of intrinsically disordered MLL‐fusion protein AF9 in complex with peptidomimetic inhibitors

Deciphering the Role of the Electrostatic Interactions Involving Gly70 in Eglin C by Total Chemical Protein Synthesis.

Structure Of Human Cytosolic X-Prolyl Aminopeptidase - A Double Mn(Ii)-Dependent Dimeric Enzyme With A Novel Three-Domain Subunit